Cuba produces one of the most potent medicines for the treatment of immunological diseases.

The Recombinant Interferon Alpha 2B (IFNrec), an antiviral produced by the Cuban biotech industry, is being used by Chinese doctors to treat patients infected by the 2019-nCoV coronavirus, which has affected more than 28,000 people and has killed 564 patients worldwide.

Since Jan. 25, the ChangHeber Company located in Changchun city has been producing the famous Cuban antiviral, which is one of 30 medicines chosen by the National Health Commission for its potential to cure respiratory diseases.

Currently, IFNrec is applied against HIV-related infections, recurrent respiratory papillomatosis, genital warts, and hepatitis types B and C. It is also effective in therapies against different types of cancer.​​​​​​​